seekingalpha comments, page-7

This guy Martin Shekryl is nothing but a phony and a blogger with no relevant experience or knowledge to comment such things.There are several holes in his story here are just a few.
*Revascor is a drug (false)
*patients followed up for 6 months(false patients had actually been followed up for median of 18 months)
*4.4 % of revascor patients died at 6 months( false death from cardiac causes was zero over the period)
* he also mentions his team reviewed quite a few CHF studies and the results were similar however no companies, trials or dates are mentioned.
*he also values MSB entirely on CHF and 50% of that for to cephalon whileconvenently forgetting about the other 9 and counting, multi billion dollar aplictions now underway or nearing human trials.

I could go on but follow the link below to find some interesting information on the author Martin Shekrel and
the lack of knowledge and qualifications this blatant downramper has.

https://sites.google.com/site/vatsire/Searching-for-Martin-Shkreli